Mark R Vondrasek

Hyatt CFO Mark Vondrasek sold 8,200 shares for $1,519,100.00, reducing stake by 47.7%

Mark R Vondrasek executed 2 separate sales totaling 8,200 shares for $1,519,100.00 on 2026-05-29, at blended average price $185.26. This represents a substantial reduction of his holdings from 17,188 shares to 8,988 shares. At the same-ticker level, Vondrasek's prior 5 trades at H show mixed timing results: 3 of 5 prior sells were well-timed at the 90-day mark (stock subsequently fell), but his two most recent 2025 sales faced headwinds initially (-9.3%, -9.7% at 30 days) before recovering into gains at 90 days. The current price of $183.65 is near the transaction prices ($185.00 and $186.00), placing the stock at -2.6% from its 52-week high of $188.50. Fundamentally, while Hyatt reported revenue of $1,748,000,000.00 and net income of $38,000,000.00 in the latest quarter with annual revenue growth of +6.8%, the company was unprofitable over its most recent full fiscal year, which may provide context for the large proportional divestiture.

Mark Vondrasek sells 10,000 shares of Hyatt Hotels at $116.80–$117.23 on 2025-03-21; stock down 17.2% in 30 days and 23.9% in 90 days.

Vondrasek executed 2 separate sales totaling 10,000 shares for $1,168,043.00, reducing his holdings by 51.7% from 19,337 to 9,337 shares on 2025-03-21. The stock has declined substantially since the transaction—dropping 17.2% over 30 days and 23.9% over 90 days—and currently trades at $121.59, down 26.9% from its 52-week high of $166.34. Notably, all 3 of Vondrasek's prior sales at Hyatt Hotels (May and March 2024) proved well-timed at the 90-day horizon, with negative 90-day returns of -1.2%, -1.1%, and -5.8% respectively, suggesting a consistent pattern of selling ahead of declines. His cross-ticker track record shows a 100.00% well-timed rate across 3 prior sells, though the current post-transaction price action (ongoing decline) aligns with that established pattern. Hyatt Hotels fundamentals show a low P/E of 9.36 and positive net income of $471,000,000.00, but annual revenue growth is flat at -0.3%, providing minimal growth momentum to offset the sharp recent price deterioration.